Global Cause
Clinical Trials Q2 2022
-
s Sponsored
Delivering better clinical trial datasets with the cloud
The cloud holds the potential to help hospitals, researchers and doctors to deliver clinical trials that scale and improve patient experience. The cloud has the potential to help life sciences organisations scale, improve the clinical trial process and offer a more patient-centric experience. Modernised clinical trials allow providers to focus on their role in discovering...
-
Increasing trust in real world data through new framework
When new treatments are brought to the market, they go through multiple assessments to ensure that they are safe, effective and good value for money. However, questions still remain. The questions that need answering during this journey are many and diverse. It is therefore no surprise that no one study design is ideal for answering...
-
How smarter trials can tackle the rising health burden
In recent decades, while global life expectancy has improved, the burden of common and other life-threatening conditions on global populations continues to rise. Despite this trend, the development of new treatments for major health conditions such as heart and lung disease, arthritis, depression and dementia has dwindled, with focus instead on rare conditions where returns...
-
s Sponsored
Keeping the new clinical trial landscape safe
With the transition to hybrid and decentralised clinical trials, the need to ensure they continue to meet stringent regulatory requirements remains paramount. Yet the shift away from the traditional trial format offers a number of benefits, such as increasing diversity in participating patient groups. Economic benefits Dr Rashmi Narayana suggests the digital elements of decentralised...
-
The five principles for good clinical trials
An abundance of tools is widely available to researchers today that can empower clinical trials to be more adaptive, connected, efficient, flexible, resilient and transparent. The use of new tools in clinical trials can help bridge the gap between research in higher- and lower-income countries. But their potential can be wasted when used without thinking...
-
A new regulation to unify the European research space
The new European Clinical Trials Regulation, which came into application on 31 January 2022, has rung in a new era for clinical trials in the EU. Over the next three years, the new regulation is going to unify the EU into one research space where the same rules and processes for the submission, evaluation and...
-
Ensuring clinical research is at the heart of care
The recent Health and Care Act will help drive a more research active NHS to deliver better healthcare for our communities. It is well established that clinical research activity in the NHS delivers clear benefits to all involved. This includes improved outcomes, lower mortality rates and increased confidence for patients in care being delivered. The...
-
Harnessing the full potential of decentralised clinical trials
Studies that are intentionally planned as decentralised clinical trials provide the best opportunity to optimise the patient-centred capabilities of decentralisation. You would not buy a sportscar and just use it for the two-mile drive to the shops. Instead, you would take it on the open road to take full advantage of its capabilities. The powerful...
-
Public involvement in research leads to a better experience for all
Clinical research shouldn’t just be shaped by the researchers conducting it – the voices of patients, carers and other members of the public are vital. A variety of voices involved in clinical research makes the clinical trial experience a better one for all, with richer results, drawing on patients’ experience and knowledge of what is...
-
How we’re working to achieve equality, diversity and inclusion in clinical trials
The pandemic has brought into sharp focus the health inequalities that currently exist in the UK, with some communities affected significantly worse by COVID-19. The pharmaceutical industry is well placed to play a key role in helping to tackle the issue of health inequalities. A key mechanism for doing this is ensuring that the evidence...